US Patent Issued to BASF AS on Oct. 14 for "Fatty acid derivatives for treating non-alcoholic steatohepatitis" (Norwegian Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,466, issued on Oct. 14, was assigned to BASF AS (Oslo, Norway).

"Fatty acid derivatives for treating non-alcoholic steatohepatitis" was invented by Hilde Steineger (Oslo, Norway), David Alan Fraser (Blommenholm, Norway) and Tore Skjaeret (Oslo, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a compound for use in therapeutic and/or prophylactic treatment of non-alcoholic steatohepatitis (NASH) and/or alcoholic steatohepatitis (ASH). The compound for use according to the invention, is an unsaturated fatty acid with an oxygen incorporated in the Beta-position, and further comprising an Alpha-substituent. More part...